PAVmed Inc.
PAVM
$0.6385
-$0.0399-5.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.00K | 10.00K | 996.00K | 979.00K | 1.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.00K | 10.00K | 996.00K | 979.00K | 1.01M |
| Cost of Revenue | 36.00K | 48.00K | 1.38M | 1.67M | 1.74M |
| Gross Profit | -28.00K | -38.00K | -385.00K | -687.00K | -734.00K |
| SG&A Expenses | 4.63M | 4.34M | 9.57M | 11.25M | 10.99M |
| Depreciation & Amortization | -- | 0.00 | 82.00K | 105.00K | 372.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.45M | 5.20M | 12.57M | 14.66M | 15.05M |
| Operating Income | -5.45M | -5.19M | -11.58M | -13.68M | -14.04M |
| Income Before Tax | 18.62M | 1.14M | 60.71M | -14.91M | -18.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.62M | 1.14M | 60.71M | -14.91M | -18.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 345.00K | 289.00K | 3.69M | 4.09M | 3.30M |
| Net Income | 18.97M | 1.43M | 64.40M | -10.83M | -15.21M |
| EBIT | -5.45M | -5.19M | -11.58M | -13.68M | -14.04M |
| EBITDA | -5.40M | -5.12M | -11.34M | -13.38M | -13.45M |
| EPS Basic | 1.28 | 0.12 | 6.43 | -1.19 | -2.62 |
| Normalized Basic EPS | -0.08 | -0.06 | -0.31 | -0.48 | -0.63 |
| EPS Diluted | 0.34 | -0.01 | 1.44 | -1.19 | -2.62 |
| Normalized Diluted EPS | -0.02 | 0.00 | -0.07 | -0.48 | -0.63 |
| Average Basic Shares Outstanding | 13.88M | 10.83M | 10.01M | 9.15M | 8.69M |
| Average Diluted Shares Outstanding | 52.50M | 131.96M | 44.48M | 9.15M | 8.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |